A5068767959- Lung Cancer Treatments and Mutations
- Neuroendocrine Tumor Research Advances
- Aerodynamics and Acoustics in Jet Flows
- Fluid Dynamics and Turbulent Flows
- Plasma and Flow Control in Aerodynamics
- HER2/EGFR in Cancer Research
- Intraperitoneal and Appendiceal Malignancies
- Lung Cancer Research Studies
- Ovarian cancer diagnosis and treatment
Joint Institute for High Temperatures
2023
Moscow Institute of Physics and Technology
2023
Cancellation of the cross-flow vortices in a swept-wing boundary layer is attempted by plasma actuator array numerical simulation. The response to stationary excitation single section measured experimentally and compared obtained from solution parabolized stability equations. A linear approach shown be held within peak-to-peak magnitude below 10% local potential flow velocity. Within model, an optimal control strategy faster suboptimal one are developed calculate voltage amplitude...
The EGFR gene mutation occurs in 15% of patients with NSCLC. Tumors such a molecular genetic profile are characterized by high sensitivity to therapy tyrosine kinase inhibitors. However, the majority EGFRm+ develop resistance 1-2 generation TKI after 9-13 months. In our study, we considered an integrated regimen combined use chemotherapy and targeted as possible way overcome acquired tumor TKIs 1–2 generations. study included IIIB / IV stages NSCLC activating mutations. Initially there were...
Abstract Objective: to demonstrate an efficacy of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in management malignant ascites (MA) patients with platinum-refractory ovarian cancer (OC). Background: MA OC can dramatically affect quality life. HIPEC is investigational treatment modality that be effective setting but evidence-based data supporting this method are lacking. Cases presentation: 2 women 50-year-old, FIGO stage IV and 60-year-old, IIIC presented at our center, both had...